Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today

VERO Insider Trading (Venus Concept)

Insider Ownership Percentage: 47.03%
Insider Buying (Last 12 Months): $207,368.50
Insider Selling (Last 12 Months): $0.00

Venus Concept Insider Trading History Chart

This chart shows the insider buying and selling history at Venus Concept by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Venus Concept Share Price & Price History

Current Price: $2.91
Price Change: Price Decrease of -0.02 (-0.68%)
As of 06/24/2021 12:43 PM ET

This chart shows the closing price history over time for VERO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

Venus Concept Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2021Domenic SerafinoCEOBuy40,000$2.46$98,400.00798,758View SEC Filing Icon  
8/24/2020Chad A ZaringInsiderBuy18,950$2.74$51,923.0021,050View SEC Filing Icon  
8/21/2020Chad A ZaringInsiderBuy21,050$2.71$57,045.5021,050View SEC Filing Icon  
See Full Table
Insider Trading at Venus Concept?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Venus Concept and related companies.

SEC Filings (Institutional Ownership Changes) for Venus Concept (NASDAQ:VERO)

43.01% of Venus Concept stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VERO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Venus Concept Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/21/2021Citadel Advisors LLC16,287$38K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC14,959$35K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC157,681$0.37M0.0%+1,390.4%0.292%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC316,144$0.74M0.0%N/A0.585%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley11,435$27K0.0%-56.3%0.021%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC11,600$27K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC16,287$38K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/18/2021California State Teachers Retirement System38,333$90K0.0%+38.0%0.071%Search for SEC Filing on Google Icon
5/17/2021Masters Capital Management LLC1,500,000$3.53M0.1%N/A2.774%Search for SEC Filing on Google Icon
5/17/2021Walleye Trading LLC13,921$33K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/17/2021Walleye Capital LLC32,483$76K0.0%N/A0.060%Search for SEC Filing on Google Icon
5/17/2021DAFNA Capital Management LLC1,230,400$2.89M0.7%-18.0%2.276%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP896,120$2.11M0.0%+28.0%1.657%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC426,011$1M0.0%+764.5%0.788%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.23,946$56K0.0%N/A0.044%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP89,423$0.21M0.0%N/A0.165%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC906,700$2.13M0.0%+5,787.7%1.677%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp84,705$0.20M0.0%+103.6%0.157%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can20,093$46K0.0%+107.0%0.037%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp229,224$0.54M0.0%+9.6%0.424%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC244,395$0.57M0.0%+11.0%0.452%Search for SEC Filing on Google Icon
5/12/2021Pura Vida Investments LLC701,486$1.65M0.0%N/A1.297%Search for SEC Filing on Google Icon
5/12/2021Essex Investment Management Co. LLC498,378$1.17M0.1%N/A0.922%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.927,199$2.18M0.0%+1.6%1.715%Search for SEC Filing on Google Icon
4/8/2021Pacifica Partners Inc.13,800$32K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.394,920$0.68M0.0%N/A0.737%Search for SEC Filing on Google Icon
2/16/2021Alyeska Investment Group L.P.394,920$0.68M0.0%N/A0.737%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp209,170$0.36M0.0%+2.3%0.391%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC15,400$27K0.0%N/A0.029%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.912,330$1.58M0.0%+12.2%2.218%Search for SEC Filing on Google Icon
11/10/2020State Street Corp206,646$0.48M0.0%+23.7%0.512%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.813,088$1.89M0.0%+7.0%2.016%Search for SEC Filing on Google Icon
8/25/2020Nuveen Asset Management LLC47,961$0.17M0.0%N/A0.119%Search for SEC Filing on Google Icon
8/20/2020Charles Schwab Investment Management Inc.39,646$0.14M0.0%N/A0.098%Search for SEC Filing on Google Icon
8/14/2020Bank of America Corp DE25,191$88K0.0%+9,334.8%0.078%Search for SEC Filing on Google Icon
8/14/2020Essex Woodlands Management Inc.12,417,856$43.34M21.3%+76.9%38.553%Search for SEC Filing on Google Icon
8/12/2020American International Group Inc.11,265$39K0.0%N/A0.035%Search for SEC Filing on Google Icon
8/12/2020Bank of New York Mellon Corp44,168$0.15M0.0%N/A0.137%Search for SEC Filing on Google Icon
8/7/2020New York State Common Retirement Fund23,600$82K0.0%N/A0.073%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG13,213$46K0.0%+2,994.4%0.041%Search for SEC Filing on Google Icon
5/2/2020SG Americas Securities LLC40,735$0.15M0.0%-24.1%0.127%Search for SEC Filing on Google Icon
2/20/2020Geode Capital Management LLC58,594$0.28M0.0%N/A0.196%Search for SEC Filing on Google Icon
2/14/2020Goldman Sachs Group Inc.63,896$0.30M0.0%N/A0.214%Search for SEC Filing on Google Icon
2/10/2020Bank of Montreal Can6,666$31K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/4/2020Cambridge Investment Research Advisors Inc.11,876$56K0.0%N/A0.040%Search for SEC Filing on Google Icon
2/3/2020Perkins Capital Management Inc.11,096$52K0.0%N/A0.037%Search for SEC Filing on Google Icon
1/28/2020SG Americas Securities LLC53,699$0.25M0.0%N/A0.181%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Venus Concept logo
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and treatment of ingrown hair; and Venus Fiore that is used for the treatment of vaginal canal, labia skin tightening, and mons pubis. The company also offers Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin; Venus Freeze Plus, a noninvasive device used in dermatologic and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides; Venus Bliss, a device is used for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance. In addition, it provides NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system; and ARTAS and ARTAS iX, a robotic systems to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Read More on Venus Concept

Today's Range

Now: $2.91
Low: $2.85
High: $2.94

50 Day Range

MA: $2.09
Low: $1.72
High: $2.93

52 Week Range

Now: $2.91
Low: $1.60
High: $4.50

Volume

2,392 shs

Average Volume

655,689 shs

Market Capitalization

$157.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.49

Who are the company insiders with the largest holdings of Venus Concept?

Venus Concept's top insider investors include:
  1. Domenic Serafino (CEO)
  2. Chad A Zaring (Insider)

Who are the major institutional investors of Venus Concept?

Venus Concept's top institutional shareholders include:
  1. Masters Capital Management LLC — 2.77%
  2. DAFNA Capital Management LLC — 2.28%
  3. BlackRock Inc. — 1.71%
  4. Renaissance Technologies LLC — 1.68%
  5. Woodline Partners LP — 1.66%
  6. Pura Vida Investments LLC — 1.30%

Which major investors are selling Venus Concept stock?

During the last quarter, VERO stock was sold by these institutional investors:
  1. DAFNA Capital Management LLC
  2. Morgan Stanley

Which major investors are buying Venus Concept stock?

Within the previous quarter, VERO stock was purchased by institutional investors including:
  1. Masters Capital Management LLC
  2. Renaissance Technologies LLC
  3. Pura Vida Investments LLC
  4. Essex Investment Management Co. LLC
  5. Nuveen Asset Management LLC
  6. Millennium Management LLC
  7. Woodline Partners LP
  8. Squarepoint Ops LLC
Within the previous year, these company insiders have bought Venus Concept stock:
  1. Domenic Serafino (CEO)
  2. Chad A Zaring (Insider)
Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today